超短血流导向装置治疗颅内动脉瘤的技术可行性、血管造影结果与临床安全性
单中心回顾性研究纳入75例患者共151个动脉瘤,86个索引动脉瘤使用93枚10-12mm超短血流导向装置,技术成功率为95.3%(82/86)。平均随访15.2个月,有影像随访的49例中完全闭塞率85.7%、充分闭塞率100%,有临床随访的61例中83.6%获得良好临床结局(mRS 0-2),术后永久性神经并发症发生率为6.7%(5/75)。
要点
- 超短血流导向装置(10-12mm)在选定颅内动脉瘤中技术成功率达95.3%,置入失败需第二枚装置补救。
- 随访完全闭塞率85.7%、充分闭塞率100%,但仅适用于有影像随访的49例亚组。
- 装置移位仅见于大脑中动脉区域且均为近端释放过度,建议由经验术者从远端向近端释放。
核心结论
- 超短血流导向装置在选定的颅内动脉瘤中技术可行,但与传统长度装置相比是否具有优势未经本研究验证,需解剖匹配比较。
研究设计与样本
- 单中心回顾性队列研究,纳入75例颅内动脉瘤患者共151个动脉瘤,其中86个索引动脉瘤使用93枚超短血流导向装置(10-12mm)。
- 主要终点为技术成功,定义为按计划将超短血流导向装置释放覆盖动脉瘤颈并在索引操作结束时完全覆盖瘤颈,按索引动脉瘤分析。
- 次要终点包括采用O'Kelly-Marotta(OKM)分级评估的血管造影结果和随访期间采用改良Rankin量表(mRS)评估的临床结局。
诊断标准与关键数值
- 技术成功率为95.3%(82/86索引动脉瘤),其余4个动脉瘤因第一枚装置移位需第二枚装置。
- 平均随访15.2±11.0个月,有影像随访的49例患者中完全闭塞42例(85.7%),充分闭塞49例(100%)。
- 有临床随访的61例患者中良好临床结局(mRS 0-2)51例(83.6%),随访期间无需再治疗。
- 术后永久性神经并发症发生于5/75例患者(6.7%)。
临床应用与阅片要点
- 装置移位仅发生在大脑中动脉区域,且每例均为装置释放过于靠近近端,提示由经验术者从远端向近端释放至关重要。
- 影像随访在75例中26例(34.7%)不可用,报告闭塞率时需注明仅适用于有影像随访的亚组。
局限性
- 单中心回顾性设计,样本量有限。
- 75例患者中26例(34.7%)无影像随访,闭塞率仅基于有影像随访的49例亚组。
- 未与传统长度血流导向装置进行解剖匹配比较,无法评估超短装置是否具有优势。
英文原文(摘要)· 点击展开
Neuroradiology . 2026 Oct 30. doi: 10.1007/s00234-026-04235-x. Online ahead of print. ABSTRACT BACKGROUND: Longer flow diverters (FDs) are often selected to facilitate deployment. Very short FDs (VSFDs; 10-12 mm) offer a targeted alternative, but technical complexity has limited their adoption, resulting in scarce clinical data. METHODS: This single-center, retrospective cohort study included patients with intracranial aneurysms who underwent VSFD treatment. The primary outcome was technical success, defined as deployment of the intended VSFD across the aneurysm neck with complete neck coverage at the end of the index procedure, and analyzed per index aneurysm. Secondary outcomes included angiographic results, assessed using the O'Kelly-Marotta (OKM) grading scale, and clinical outcomes, evaluated with the modified Rankin Scale (mRS) during follow-up. Statistical analyses were performed using R software (version 4.5.2; R Foundation for Statistical Computing, Vienna, Austria). RESULTS: Seventy-five patients harboring 151 aneurysms were included, with 86 index aneurysms treated using 93 VSFDs. Technical success was achieved in 82 of 86 index aneurysms (95.3%); the remaining 4 aneurysms required a second device because of malposition of the first. At a mean follow-up of 15.2 ± 11.0 months, complete occlusion was achieved in 42 of 49 patients with imaging follow-up (85.7%) and adequate occlusion in 49 of 49 (100%); imaging follow-up was unavailable in 26 of 75 patients (34.7%), so these proportions apply to the imaged subgroup only. Favorable clinical outcome (mRS 0-2) was obtained in 51 of 61 patients with clinical follow-up (83.6%), and no retreatment was required during follow-up. Postprocedural permanent neurological complications occurred in 5 of 75 patients (6.7%). CONCLUSIONS: VSFDs were technically feasible in selected intracranial aneurysms. Whether they offer any advantage over conventional-length devices was not tested in this study and requires anatomically matched comparison. Device malposition occurred only in the middle cerebral artery territory, and in every case the device had been deployed too proximally, so deployment from distal to proximal by experienced operators is essential. PMID: 42961457 | DOI: 10.1007/s00234-026-04235-x
引用
- Neuroradiology(PubMed 期刊源):Very short flow diverters for intracranial aneurysms: technical feasibility, angiographic outcomes, and clinical safety across diverse cerebrovascular locations
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。